Patients rank Coloplast as the best company
30 Apr 2012
In a new global study, patients say that Coloplast has the best customer focus, the most useful products and the strongest patient safety. The study places Coloplast in front of competitors such as Smith & Nephew and Johnson & Johnson.
In a study covering 18 leading medical device companies, patients rate Coloplast as no. 1 in six different areas. The study was done by PatientView, an independent healthcare consultancy, and is based on feedback from 300 patient groups from 42 countries worldwide.
The study looked at the corporate reputation of the medical device industry as a whole, and of 18 individual medical device companies. It used six indicators to measure each company’s performance:
- Whether the company has an effective patient-centred strategy
- The quality of the information that the company provides to patients
- The company’s record on patient safety
- The usefulness of the company’s products to patients
- The company’s record of transparency with external healthcare stakeholders
- Whether the company acts with integrity
Coloplast ranked first in all six of the study’s indicators.
Strong customer focus key to success
Coloplast makes products and services for people with very personal and private medical conditions – the company calls this “intimate healthcare”. The business areas include ostomy care, continence care, urology as well as wound and skin care.
Nicolas Nemery, Senior Vice President at Coloplast, believes the study results reflect Coloplast’s strong customer focus.
“We care for our customers and want to make a real difference to their lives – and this study tells me that they appreciate it”, Nicolas Nemery says.
“Most of our customers have had serious accidents or diseases, and we want to help them regain full and meaningful lives. By designing products that work, are easy to use and don’t look like medical products, we hope to remove the problems and stigma that many of our customers live with – and we can only do this by listening to their needs and engaging them in our product innovation, so it is great to see that they like to engage with us.”
Read more about the study at Patient View’s webpage.
Read more about Coloplast at www.coloplast.com.
FACTS
Final ranking for the top 6 companies
Medical device company | Indicator | |||||||
I | II | III | IV | V | VI | Total score | Final rank | |
Coloplast A/S | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 1st |
Medtronic, Inc. | 3 | 2 | 2 | 2 | 2 | 2 | 13 | 2nd |
Smith & Nephew | 5 | 3 | 4 | 6 | 4 | 6 | 28 | 3rd |
Roche Diagnostics | 2 | 4 | 9 | 6 | 3 | 5 | 29 | 4th |
Abbott | 5 | 8 | 6 | 8 | 5 | 3 | 35 | =5th |
Johnson & Johnson | 4 | 4 | 8 | 5 | 7 | 7 | 35 | =5th |
Table: PatientView, April 2012
PatientView’s study looked at 18 companies:
- Abbott
- Baxter International
- B. Braun Melsungen AG
- Becton, Dickinson and Company (BD)
- Boston Scientific
- Coloplast A/S
- Fresenius Medical Care (FMC)
- GE Healthcare
- Johnson & Johnson
- Medtronic, Inc
- Olympus Medical Systems Business
- Philips Healthcare
- Roche Diagnostics
- Siemens Healthcare
- Smith & Nephew
- St. Jude Medical, Inc
- Toshiba Medical Systems Corporation
- 3M Health Care
The patient groups questioned represent a minimum of 1.5 million patients and cover a wide range of fields such as neurology, cancer, diabetes and mental health. The majority (23%) are based in the UK, 13% in the US, 8% in Germany, and 5% in Belgium and Canada – most other countries are also represented. The study was carried out from mid-February to late-March 2012.